undamentalytics Newsletter

GSK plc trades by members of Congress

Purchases and sales of GSK plc shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 0 trades None disclosed
Sales, last 12 months 0 trades None disclosed
Members trading, last 12 months 0 74 purchases and sales since January 3, 2015
GSK plc trades disclosed by members of Congress
Report
Lisa C. McClain House · R-MI 9 Sale (full)$1,001 - $15,000 · Spouse Nov 21, 2025 Oct 31, 2025 Filing for GSK on Oct 31, 2025
Lisa C. McClain House · R-MI 9 Purchase$1,001 - $15,000 · Spouse Nov 21, 2025 Oct 30, 2025 Filing for GSK on Oct 30, 2025
Lisa C. McClain House · R-MI 9 Sale (full)$1,001 - $15,000 · Spouse Nov 21, 2025 Oct 30, 2025 Filing for GSK on Oct 30, 2025
Val T. Hoyle House · D-OR 4 Sale (full)$1,001 - $15,000 · Spouse Oct 10, 2025 Sep 23, 2025 Filing for GSK on Sep 23, 2025
Lisa C. McClain House · R-MI 9 Purchase$1,001 - $15,000 · Spouse Sep 12, 2025 Aug 4, 2025 Filing for GSK on Aug 4, 2025
Robert B. Aderholt House · R-AL 4 Sale (full)$1,001 - $15,000 Sep 10, 2025 Jul 28, 2025 Filing for GSK on Jul 28, 2025
Lisa C. McClain House · R-MI 9 Sale (full)$1,001 - $15,000 · Spouse Aug 13, 2025 Jun 24, 2025 Filing for GSK on Jun 24, 2025
Lisa C. McClain House · R-MI 9 Purchase$1,001 - $15,000 · Spouse Aug 13, 2025 Jun 17, 2025 Filing for GSK on Jun 17, 2025
Bruce Westerman House · R-AR 4 Sale (full)$1,001 - $15,000 May 12, 2025 Apr 21, 2025 Filing for GSK on Apr 21, 2025
Bruce Westerman House · R-AR 4 Purchase$1,001 - $15,000 Apr 16, 2025 Mar 3, 2025 Filing for GSK on Mar 3, 2025
Marjorie Taylor Greene House · R-GA 14 Purchase$1,001 - $15,000 Nov 27, 2024 Nov 25, 2024 Filing for GSK on Nov 25, 2024
Val T. Hoyle House · D-OR 4 Purchase$1,001 - $15,000 · Spouse Sep 12, 2025 Nov 18, 2024 Filing for GSK on Nov 18, 2024
Marjorie Taylor Greene House · R-GA 14 Purchase$1,001 - $15,000 Sep 4, 2024 Sep 3, 2024 Filing for GSK on Sep 3, 2024
Daniel S. Goldman House · D-NY 10 Sale (full)$15,001 - $50,000 Aug 13, 2023 Jul 10, 2023 Filing for GSK on Jul 10, 2023
Virginia Foxx House · R-NC 5 Sale (full)$50,001 - $100,000 · Joint Apr 4, 2023 Mar 1, 2023 Filing for GSK on Mar 1, 2023
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Sep 8, 2022 Aug 16, 2022 Filing for GSK on Aug 16, 2022
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint Sep 8, 2022 Aug 10, 2022 Filing for GSK on Aug 10, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Sep 8, 2022 Aug 9, 2022 Filing for GSK on Aug 9, 2022
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint Sep 8, 2022 Aug 5, 2022 Filing for GSK on Aug 5, 2022
Virginia Foxx House · R-NC 5 Sale (partial)$100,001 - $250,000 · Joint Aug 5, 2022 Jul 12, 2022 Filing for GSK on Jul 12, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Aug 5, 2022 Jul 6, 2022 Filing for GSK on Jul 6, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint May 4, 2022 Apr 8, 2022 Filing for GSK on Apr 8, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Mar 7, 2022 Feb 22, 2022 Filing for GSK on Feb 22, 2022
John H. Rutherford House · R-FL 4 Sale (full)$1,001 - $15,000 Mar 16, 2022 Feb 17, 2022 Filing for GSK on Feb 17, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Feb 4, 2022 Jan 14, 2022 Filing for GSK on Jan 14, 2022
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 2, 2021 Oct 8, 2021 Filing for GSK on Oct 8, 2021
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Aug 2, 2021 Jul 9, 2021 Filing for GSK on Jul 9, 2021
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Aug 15, 2021 Jun 4, 2021 Filing for GSK on Jun 4, 2021
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Aug 15, 2021 Jun 4, 2021 Filing for GSK on Jun 4, 2021
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint May 5, 2021 Apr 9, 2021 Filing for GSK on Apr 9, 2021
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Feb 1, 2021 Jan 15, 2021 Filing for GSK on Jan 15, 2021
Katherine M. Clark House · D-MA 5 Purchase$1,001 - $15,000 · Spouse Dec 28, 2020 Nov 5, 2020 Filing for GSK on Nov 5, 2020
Katherine M. Clark House · D-MA 5 Purchase$1,001 - $15,000 · Spouse Dec 28, 2020 Nov 5, 2020 Filing for GSK on Nov 5, 2020
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Dec 3, 2020 Oct 22, 2020 Filing for GSK on Oct 22, 2020
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Dec 3, 2020 Oct 22, 2020 Filing for GSK on Oct 22, 2020
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 6, 2020 Oct 9, 2020 Filing for GSK on Oct 9, 2020
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Aug 10, 2020 Jul 10, 2020 Filing for GSK on Jul 10, 2020
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint May 4, 2020 Apr 13, 2020 Filing for GSK on Apr 13, 2020
Greg Gianforte House · MT Purchase$50,001 - $100,000 · Joint Apr 7, 2020 Mar 18, 2020 Filing for GSK on Mar 18, 2020
Katherine M. Clark House · D-MA 5 Purchase$1,001 - $15,000 · Spouse Apr 20, 2020 Mar 2, 2020 Filing for GSK on Mar 2, 2020
Katherine M. Clark House · D-MA 5 Purchase$1,001 - $15,000 · Spouse Apr 20, 2020 Mar 2, 2020 Filing for GSK on Mar 2, 2020
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Feb 3, 2020 Jan 10, 2020 Filing for GSK on Jan 10, 2020
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 12, 2019 Oct 11, 2019 Filing for GSK on Oct 11, 2019
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Aug 8, 2019 Jul 12, 2019 Filing for GSK on Jul 12, 2019
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint May 10, 2019 Apr 12, 2019 Filing for GSK on Apr 12, 2019
Van Taylor House · R-TX 3 Sale (full)$15,001 - $50,000 · Spouse Apr 15, 2019 Mar 25, 2019 Filing for GSK on Mar 25, 2019
Van Taylor House · R-TX 3 Sale (full)$15,001 - $50,000 · Spouse Apr 15, 2019 Mar 25, 2019 Filing for GSK on Mar 25, 2019
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Feb 5, 2019 Jan 10, 2019 Filing for GSK on Jan 10, 2019
Greg Gianforte House · MT Sale (partial)$15,001 - $50,000 · Joint Jan 23, 2019 Dec 21, 2018 Filing for GSK on Dec 21, 2018
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint Jan 7, 2019 Dec 11, 2018 Filing for GSK on Dec 11, 2018
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 5, 2018 Oct 9, 2018 Filing for GSK on Oct 9, 2018
Zoe Lofgren House · D-CA 19 Sale (full)$1,001 - $15,000 · Spouse Sep 13, 2018 Aug 30, 2018 Filing for GSK on Aug 30, 2018
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint May 10, 2018 Apr 12, 2018 Filing for GSK on Apr 12, 2018
Greg Gianforte House · MT Purchase$1,001 - $15,000 · Joint Apr 13, 2018 Mar 26, 2018 Filing for GSK on Mar 26, 2018
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Feb 14, 2018 Jan 3, 2018 Filing for GSK on Jan 3, 2018
Katherine M. Clark House · D-MA 5 Sale (full)$1,001 - $15,000 · Spouse Feb 14, 2018 Jan 3, 2018 Filing for GSK on Jan 3, 2018
Greg Gianforte House · MT Sale (full)$50,001 - $100,000 · Joint Jan 4, 2018 Dec 14, 2017 Filing for GSK on Dec 14, 2017
Ken Buck House · R-CO 4 Sale (full)$1,001 - $15,000 Dec 11, 2017 Nov 7, 2017 Filing for GSK on Nov 7, 2017
Ken Buck House · R-CO 4 Purchase$1,001 - $15,000 Nov 2, 2017 Oct 27, 2017 Filing for GSK on Oct 27, 2017
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 8, 2017 Oct 25, 2017 Filing for GSK on Oct 25, 2017
Pete Sessions House · R-TX 32 Purchase$1,001 - $15,000 · Spouse Oct 25, 2017 Oct 25, 2017 Filing for GSK on Oct 25, 2017
Virginia Foxx House · R-NC 5 Purchase$1,001 - $15,000 · Joint Nov 8, 2017 Oct 24, 2017 Filing for GSK on Oct 24, 2017
Pete Sessions House · R-TX 32 Sale (full)$1,001 - $15,000 · Spouse Aug 31, 2017 Aug 31, 2017 Filing for GSK on Aug 31, 2017
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint Sep 1, 2017 Aug 4, 2017 Filing for GSK on Aug 4, 2017
John H. Rutherford House · R-FL 4 Purchase$1,001 - $15,000 Aug 20, 2018 Jul 11, 2017 Filing for GSK on Jul 11, 2017
Zoe Lofgren House · D-CA 19 Purchase$1,001 - $15,000 · Spouse Jul 18, 2017 Jun 15, 2017 Filing for GSK on Jun 15, 2017
Charlie Joseph Crist House · FL Sale (full)$50,001 - $100,000 Mar 23, 2017 Feb 22, 2017 Filing for GSK on Feb 22, 2017
Pete Sessions House · R-TX 32 Purchase$1,001 - $15,000 · Spouse May 1, 2017 Dec 1, 2016 Filing for GSK on Dec 1, 2016
Katherine M. Clark House · D-MA 5 Purchase$1,001 - $15,000 · Spouse May 25, 2017 Oct 11, 2016 Filing for GSK on Oct 11, 2016
E. Scott Rigell House · VA Purchase$15,001 - $50,000 · Spouse Apr 28, 2016 Mar 8, 2016 Filing for GSK on Mar 8, 2016
Virginia Foxx House · R-NC 5 Purchase$15,001 - $50,000 · Joint Mar 7, 2016 Feb 11, 2016 Filing for GSK on Feb 11, 2016
Thomas MacArthur House · NJ Sale (full)$1,001 - $15,000 Jun 7, 2015 May 27, 2015 Filing for GSK on May 27, 2015
K. Michael Conaway House · TX Sale (full)$1,001 - $15,000 · Spouse May 5, 2015 Apr 27, 2015 Filing for GSK on Apr 27, 2015
Thomas J. Rooney House · FL Sale (full)$1,001 - $15,000 Jan 16, 2017 Jul 29, 2014 Filing for GSK on Jul 29, 2014

When several House members traded GSK plc

Months when 2 or more House members became net buyers, or 3 or more net sellers, of GSK plc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. Only House members' electronic trade reports are included; Senate reports and reports filed on paper are not. After the 7 buying crowds with six months of prices, it averaged −2.9% against the index. After 1 selling crowd, +9.2%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
September 30, 20252 buying+11.8%+33.0%−2.7%
April 30, 20203 buying−15.3%−30.8%−52.4%
May 31, 20182 buying−4.2%+1.9%−1.9%
February 28, 20183 selling+12.7%+9.2%+12.0%
November 30, 20173 buying+3.5%+15.0%+20.2%
September 29, 20172 buying−18.2%−4.9%−13.9%
May 31, 20172 buying−11.9%−26.6%−17.4%
April 29, 20162 buying+0.6%−7.9%−18.0%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to GSK plc · Insider trading · Funds · All trades by members of Congress